HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 240.12 billion as of March 9, 2026. Its market cap has decreased by -71.66% in one year.

Market Cap

240.12B

Enterprise Value

258.85B

Revenue

63.25B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,860.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 240.12B, an increase of 126.95%. That is a compound annual growth rate of 5.27%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	240.12B	-4.67%
Dec 30, 2025	251.87B	-73.05%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EASY BIO,Inc.	233.89B
Genexine	231.04B
Helixmith	294.70B
iNtRON Biotechnology	197.72B
Vaxcell-Bio Therapeutics	195.83B
Macrogen	185.06B
JETEMA,	321.22B
Bioneer	325.73B

Market Cap Rankings